BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6902725)

  • 1. Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments.
    McDonald JA; Kelley DG
    J Biol Chem; 1980 Sep; 255(18):8848-58. PubMed ID: 6902725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatin-binding domain-specific anti-human plasma fibronectin Fab' inhibits fibronectin-mediated gelatin binding but not cell spreading.
    McDonald JA; Broekelmann TJ; Kelley DG; Villiger B
    J Biol Chem; 1981 Jun; 256(11):5583-7. PubMed ID: 7240156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis of gelatin-bound fibronectin by activated leukocytes: a role for leukocyte elastase.
    Daudi I; Gudewicz PW; Saba TM; Cho E; Vincent P
    J Leukoc Biol; 1991 Oct; 50(4):331-40. PubMed ID: 1655937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte elastase-independent proteolysis of gelatin-bound fibronectin by inflammatory macrophages.
    Daudi I; Gudewicz PW; Saba TM; Cho E; Frewin MB
    Inflammation; 1991 Dec; 15(6):481-95. PubMed ID: 1757131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interdomain cleavage of plasma fibronectin by zinc-metalloproteinase from Serratia marcescens.
    Molla A; Tanase S; Hong YM; Maeda H
    Biochim Biophys Acta; 1988 Jun; 955(1):77-85. PubMed ID: 3289620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation-enhancing activity of gelatin-binding fragments of fibronectin.
    De Petro G; Barlati S; Vartio T; Vaheri A
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):4965-9. PubMed ID: 6458038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of fibronectin and its gelatin-binding domains with fluorescent-labeled chains of type I collagen.
    Ingham KC; Brew SA; Isaacs BS
    J Biol Chem; 1988 Apr; 263(10):4624-8. PubMed ID: 3127386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.
    Zhu BC; Fisher SF; Pande H; Calaycay J; Shively JE; Laine RA
    J Biol Chem; 1984 Mar; 259(6):3962-70. PubMed ID: 6423638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alignment of biologically active domains in the fibronectin molecule.
    Ruoslahti E; Hayman EG; Engvall E; Cothran WC; Butler WT
    J Biol Chem; 1981 Jul; 256(14):7277-81. PubMed ID: 6788765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments.
    Fesus L; Metsis ML; Muszbek L; Koteliansky VE
    Eur J Biochem; 1986 Jan; 154(2):371-4. PubMed ID: 2867902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of elastase from monocytes adherent to a fibronectin-gelatin surface.
    Xie DL; Meyers R; Homandberg GA
    Blood; 1993 Jan; 81(1):186-92. PubMed ID: 8417788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody characterization of two distant sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix assembly.
    Nagai T; Yamakawa N; Aota S; Yamada SS; Akiyama SK; Olden K; Yamada KM
    J Cell Biol; 1991 Sep; 114(6):1295-305. PubMed ID: 1716636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic chemotactic activity of fibronectin for human monocytes resides in the 120-kDa fibroblastic cell-binding fragment.
    Clark RA; Wikner NE; Doherty DE; Norris DA
    J Biol Chem; 1988 Aug; 263(24):12115-23. PubMed ID: 3403561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subtilisin and cyanogen bromide cleavage products of fibronectin that retain gelatin-binding activity.
    Gold LI; Garcia-Pardo A; Frangione B; Franklin EC; Pearlstein E
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4803-7. PubMed ID: 116223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function.
    Yamada KM; Kennedy DW
    J Cell Biol; 1984 Jul; 99(1 Pt 1):29-36. PubMed ID: 6736130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of biologically active fragments from human plasma-fibronectin by murine T cell-specific proteinase 1 (TSP-1).
    Simon MM; Prester M; Nerz G; Kramer MD; Fruth U
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():107-12. PubMed ID: 3060134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuron-specific interactions with two neurite-promoting fragments of fibronectin.
    Rogers SL; McCarthy JB; Palm SL; Furcht LT; Letourneau PC
    J Neurosci; 1985 Feb; 5(2):369-78. PubMed ID: 3973671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and preliminary characterization of monoclonal antibodies to rat plasma fibronectin.
    Hasty DL; Mainardi CL
    Biochim Biophys Acta; 1982 Dec; 709(2):318-24. PubMed ID: 6185152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet interactions with fibronectin: divalent cation-independent platelet adhesion to the gelatin-binding domain of fibronectin.
    Winters KJ; Walsh JJ; Rubin BG; Santoro SA
    Blood; 1993 Apr; 81(7):1778-86. PubMed ID: 8461464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.